What is the recommended management for an acute gout attack?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Gout Attack

Corticosteroids, NSAIDs, or colchicine should be used as first-line therapy for acute gout attacks, with treatment initiated within 24 hours of symptom onset for optimal outcomes. 1, 2

First-Line Treatment Options

Corticosteroids

  • Considered first-line therapy in patients without contraindications due to safety profile and low cost 1
  • Prednisolone 35 mg for 5 days has been successfully used to treat acute gout 1
  • Alternative dosing: oral prednisone 0.5 mg/kg per day for 5-10 days at full dose then stop, or 2-5 days at full dose followed by 7-10 day taper 1, 3
  • Contraindicated in patients with systemic fungal infections 1
  • Potential adverse effects with long-term use include dysphoria, mood disorders, elevated blood glucose, immune suppression, and fluid retention 1

NSAIDs

  • Use full FDA-approved anti-inflammatory/analgesic doses 1
  • FDA-approved NSAIDs for acute gout include naproxen, indomethacin, and sulindac 1
  • No evidence that indomethacin is more efficacious than other NSAIDs 1
  • Contraindicated in patients with renal disease, heart failure, or cirrhosis 1
  • Common adverse effects include dyspepsia and potential gastrointestinal complications 1

Colchicine

  • Low-dose colchicine regimen (1.2 mg followed by 0.6 mg 1 hour later) is as effective as higher doses with fewer gastrointestinal adverse effects 1
  • If patient is already on prophylactic colchicine, use alternative therapy (NSAID or corticosteroid) 1
  • Contraindicated in patients with renal or hepatic impairment who are using potent cytochrome P450 3A4 inhibitors or P-glycoprotein inhibitors 1
  • More expensive than NSAIDs or corticosteroids, even with generic formulation 1

Treatment Algorithm Based on Joint Involvement and Pain Severity

Mild to Moderate Pain (≤6/10) with Limited Joint Involvement

  • Monotherapy with any of the first-line agents is appropriate 1
  • For 1-3 small joints or 1-2 large joints, use single agent therapy 1

Severe Pain or Polyarticular Involvement

  • Combination therapy is appropriate for severe pain or polyarticular attacks 1, 3
  • Effective combinations include:
    • Colchicine plus NSAIDs 3
    • Oral corticosteroids plus colchicine 3
    • Intra-articular steroids with any other modality 3

Important Principles

  • Initiate treatment within 24 hours of symptom onset for best results 1, 2
  • Continue established urate-lowering therapy without interruption during an acute attack 1, 2
  • Educate patients to initiate treatment upon first signs of an acute attack 1
  • For patients with a single or infrequent gout attacks (<2 per year), long-term urate-lowering therapy is not recommended 1

Common Pitfalls to Avoid

  • Delaying treatment beyond 24 hours of symptom onset significantly reduces effectiveness 2
  • Stopping urate-lowering therapy during an acute attack can worsen and prolong symptoms 2
  • Using high-dose colchicine regimens increases risk of adverse effects without improving efficacy 1
  • Combining NSAIDs with systemic corticosteroids increases gastrointestinal toxicity risk 2

Special Considerations

  • For patients with renal impairment: corticosteroids are generally safer than NSAIDs or colchicine 1
  • For patients with diabetes: NSAIDs or colchicine may be preferred over corticosteroids 1
  • For patients with gastrointestinal risk factors: corticosteroids or low-dose colchicine are preferred over NSAIDs 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Gouty Arthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Urate Nephropathy in Patients with Acute Polyarticular Gout Attack

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.